Traduction de «opioid drug » (Anglais → Néerlandais) :

TERMINOLOGIE

narcotic | narcotic agent | narcotic analgesic | narcotic analgesic drug | opioid | opioid analgesic | opioid analgesic drug | opioid drug
narcotisch analgeticum

...lass of substances (e.g. opioid drugs), or for a wider range of pharmacologically different psychoactive substances. Chronic alcoholism Dipsomania Drug addiction .3 Withdrawal state A group of symptoms of variable clustering and severity occurring on absolute or relative withdrawal of a psychoactive substance after persistent use of that substance. The onset and course of the withdrawal state are time-limited and are related to the type of psychoactive substance and dose being used immediately before cessation or reduction of use. The withdrawal state may be complicated by convulsions. .4 Withdrawal state with delirium A condition where the withdrawal state as defined in the common fourth character .3 is complicated by delirium as defined in F05.-. Convulsions may also occur. When organic factors are also considered to play a role in the etiology, the condition should be classified to F05.8. Delirium tremens (alcohol-induced) .5 Psychotic disorder A cluster of psychotic phenomena that occur during or following psychoactive substance use but that are not explained on the basis of acute intoxication alone and do not form part of a withdrawal state. The disorder is characterized by hallucinations (typically auditory, but often in more than one sensory modality), perceptual distortions, delusions (often of a paranoid or persecutory nature), psychomotor disturbances (excitement or stupor), and an abnormal affect, which may range from intense fear to ecstasy. The sensorium is usually clear but some degree of clouding of consciousness, though not severe confusion, may be present. Alcoholic:hallucinosis | jealousy | paranoia | psychosis NOS | Excl.: alcohol- or other psychoactive substance-induced residual and late-onset psychotic disorder (F10-F19 with common fourth character .7) .6 Amnesic syndrome A syndrome associated with chronic prominent impairment of recent and remote memory. Immediate recall is usually preserved and recent memory is characteristically more disturbed than remote memory. Disturbances of time sense and ordering of events are usually evident, as are difficulties in learning new material. Confabulation may be marked but is not invariably present. Other cognitive functions are usually relatively well preserved and amnesic defects are out of proportion to other disturbances. Amnestic disorder, alcohol- or drug-induced Korsakov's psychosis or syndrome, alcohol- or other psychoactive substance-induced or unspecified Excl.: nonalcoholic Korsakov's psychosis or syndrome (F04) .7 Residual and late-onset psychotic disorder A disorder in which alcohol- or psychoactive substance-induced changes of cognition, affect, personality, or behaviour persist beyond the period during which a direct psychoactive substance-related effect might reasonably be assumed to be operating. Onset of the disorder should be directly related to the use of the psychoactive substance. Cases in which initial onset of the state occurs later than episode(s) of such substance use should be coded here only where clear and strong evidence is available to attribute the state to the residual effect of the psychoactive substance. Flashbacks may be distinguished from psychotic state partly by their episodic nature, frequently of very short duration, and by their duplication of previous alcohol- or other psychoactive substance-related experiences. Alcoholic dementia NOS Chronic alcoholic brain syndrome Dementia and other milder forms of persisting impairment of cognitive functions Flashbacks Late-onset psychoactive substance-induced psychotic disorder Posthallucinogen perception disorder Residual:affective disorder | disorder of personality and behaviour | Excl.: alcohol- or psychoactive substance-induced:Korsakov's syndrome (F10-F19 with common fourth character .6) | psychotic state (F10-F19 with common fourth character .5) | .8 Other mental and behavioural disorders .9 Unspecified mental and behavioural disorder | Acute drunkenness in alcoholism Bad trips (drugs) Drunkenness NOS Pathological intoxication Trance and possession disorders in psychoactive substance intoxication | Psychoactive substance abuse | Chronic alcoholism Dipsomania Drug addiction | Delirium tremens (alcohol-induced) | Alcoholic:hallucinosis | jealousy | paranoia | psychosis NOS | Amnestic disorder, alcohol- or drug-induced Korsakov's psychosis or syndrome, alcohol- or other psychoactive substance-induced or unspecified | Alcoholic dementia NOS Chronic alcoholic brain syndrome Dementia and other milder forms of persisting impairment of cognitive functions Flashbacks Late-onset psychoactive substance-induced psychotic disorder Posthallucinogen perception disorder Residual:affective disorder | disorder of personality and behaviour ...
Omschrijving: Dit blok omvat een grote verscheidenheid van stoornissen van verschillende ernst en klinische vorm, die evenwel alle aan het gebruik van een of meer psychoactieve middelen, al dan niet op medisch voorschrift, zijn toe te schrijven. De betrokken stof wordt aangegeven door middel van het derde teken van de code en het vierde teken specificeert de klinische toestand; deze codering dient, waar nodig, gebruikt te worden voor elk gespecificeerd middel, met dien verstande dat niet elk vierde teken van toepassing is op elke stof. ...

opiate (niet: opioid) | opium-like drug
opiaat | opiumbevattend geneesmiddel

opioid substitution | opioid substitution therapy | opioid substitution treatment | substitution therapy | substitution treatment | OST [Abbr.]
behandeling door middel van opioïdensubstitutie | opioïdensubstitutiebehandeling | opioïdensubstitutietherapie

drug addiction [ drug abuse | drug-taking | fight against drugs | drug addicts(UNBIS) ]
drugverslaving [ drugbestrijding | druggebruik | gebruik van verdovende middelen ]

EU Action Plan on Drugs | EU Action Plan to Combat Drugs | EU Drugs Action Plan | European Union Action Plan on Drugs | European Union Action Plan to Combat Drugs | European Union Drugs Action Plan
actieplan van de Europese Unie inzake drugsbestrijding | EU-drugsactieplan

accidental overdose of drug, wrong drug given or taken in error, and drug taken inadvertently accidents in the use of drugs, medicaments and biological substances in medical and surgical procedures (self-inflicted) poisoning, when not specified whether accidental or with intent to harm. Follow legal rulings when available (see note at Y10-Y34).
ongevallen bij gebruik van geneesmiddelen en biologische stoffen bij medische en chirurgische verrichtingen | onopzettelijke overdosis van geneesmiddel, onopzettelijke toediening of inname van onjuist geneesmiddel en per ongeluk ingenomen geneesmiddel | zelf teweeggebrachte vergiftiging, waarbij niet is aangegeven of al dan niet sprake is van opzet. Volg wettelijke voorschriften indien van toepassing [zie opmerking bij Y10-Y34]

Mental and behavioural disorders due to use of opioids
psychische stoornissen en gedragsstoornissen door gebruik van opioïden

anthelmintic | anti-worm drug
anthelminthicum | wormdrijvend middel

anaesthetic | drug to deaden sensation
anestheticum | pijnverdovend middel

TRADUCTIONS EN CONTEXTE

the trends towards non-opioid drug use as well as the emergence and spread of new psychoactive substances.
de trends naar het gebruiken van niet-opioïde drugs, alsook de opkomst en de verspreiding van nieuwe psychoactieve middelen.

Expand the availability, accessibility and coverage of effective and diversified drug treatment across the EU to problem and dependent drug users including non-opioids users, so that all those who wish to enter drug treatment can do so, according to relevant needs.
Verruimen van de beschikbaarheid, toegankelijkheid en reikwijdte van doeltreffende en gediversifieerde drugsbehandeling in de gehele Unie, naar problematische drugsgebruikers en drugsverslaafden, inclusief gebruikers van niet-opioïden, zodat al degenen die een drugsbehandeling wensen, die onmiddellijk kunnen krijgen op basis van de relevante behoeften.

expanding drug treatment, including for non-opioid users, as well as integrated models of mental and physical health care.
het verruimen van drugsbehandeling, met inbegrip van de behandeling voor gebruikers van niet-opioïden, en het uitbreiden van geïntegreerde zorgmodellen voor mentale en fysieke gezondheid.

[8] According to The European Monitoring Centre for Drugs and Drug Addiction’s 2012 annual report on the state of the drugs problem in Europe, drug-induced deaths accounted for 4% of all deaths of Europeans aged 15–39 in 2011 and an estimated 1.4 million Europeans are opioid users.
[8] Volgens het jaarverslag van 2012 van het Europees Waarnemingscentrum voor drugs en drugsverslaving inzake de status van het drugsprobleem in Europa, wordt 4% van alle sterfgevallen bij Europese burgers tussen 15 en 39 jaar in 2011 gelinkt aan drugsgebruik, en naar schatting 1,4 miljoen Europeanen gebruiken opiaat.

the trends towards non-opioid drug use as well as the emergence and spread of new psychoactive substances;
de trends naar het gebruiken van niet-opioïde drugs, alsook de opkomst en de verspreiding van nieuwe psychoactieve middelen;

Around half of the drug users entering specialised treatment in Europe report opioids as their main problem drug. Today's report highlights new concerns over the use of opioids other than heroin and the potential for HIV outbreaks among people who inject drugs.
Ongeveer de helft van de drugsgebruikers in Europa die in een gespecialiseerd behandelingscentrum worden opgenomen, verklaart dat opioïden hun grootste probleem vormen. Volgens het verslag van vandaag is er nieuwe bezorgdheid ontstaan over het gebruik van andere opioïden dan heroïne en de mogelijke verspreiding van hiv onder intraveneuze drugsgebruikers.

– having regard to the UN's Economic and Social Council (ECOSOC) Resolution 2005/25 of 22 July 2005 on treatment of pain using opioid analgesics, in which the feasibility of a possible assistance mechanism that would facilitate such treatment is discussed, to ECOSOC Resolution 2004/40 of 21 July 2004 on guidelines for psychosocially assisted pharmacological treatment of persons dependent on opioids, to ECOSOC Resolution 2005/26 of 22 July 2005 on demand for and supply of opiates used to meet medical and scientific needs, to World Health Assembly (WHA) Resolution 58.22 of 25 May 2005 on cancer prevention and control, to WHA Resolution 55.14 of 18 May 2002 on ensuring accessibility of essential medicines, and to the final recommendations of the 12th International Conference of Drug Regulatory Authorities, held in Seoul from 3-6 April 2006, urging regulators to work for better access to narcotic painkillers;
– gezien Resolutie 2005/25 van 22 juli 2005 van de Economische en Sociale Raad van de VN (ECOSOC) over adequate pijnbehandeling met opioïde pijnstillers, waarin de haalbaarheid van een eventueel ondersteuningsmechanisme ter facilitering van een dergelijke behandeling aan de orde wordt gesteld, ECOSOC-Resolutie 2004/40 van 21 juli 2004 over richtsnoeren voor de medicamenteuze behandeling met psychosociale ondersteuning van opiaatverslaafde personen, en ECOSOC-Resolutie 2005/26 van 22 juli 2005 over de vraag naar en levering van opiaten voor medische en wetenschappelijke doeleinden, alsmede gezien Resolutie 58.22 van 25 mei 2005 van de Algemene Vergadering van de Wereldgezondheidsorganisatie (WHA) over kankerpreventie en -bestrijding, WHA-Resolutie 55.14 van 18 mei 2002 over de gewaarborgde beschikbaarheid van essentiële medicijnen, en gezien de slotaanbevelingen van de 12de Internationale Conferentie van regelgevende instanties op het gebied van geneesmiddelen, die van 3-6 april 2006 in Seoel is gehouden, waarbij de regelgevers werden opgeroepen te werken aan een betere beschikbaarheid van narcotische pijnstillers,